title: Management of primary herpetic gingivostomatitis in young children.
abstract: OBJECTIVE
  To review the treatment of primary herpetic gingivostomatitis at a children's hospital.
  
  
  METHODS
  A review of charts from 1999 to 2003.
  
  
  RESULTS
  Forty-eight cases were identified. They ranged in age from 8 months to 12 years, with a median age of 2 years 7 months. All children were treated with fluids and analgesics; 11 children were treated with fluids and analgesics exclusively. Thirty-five children were treated with a mixture of Maalox and diphenhydramine, 8 with acyclovir, and 7 with viscous lidocaine; 11 children were treated with 2 or more of these regimens. Both the Maalox and diphenhydramine mixture and the viscous lidocaine were administered as swish and swallow, swish and spit, or by application with a swab as frequently as every hour or as infrequently as every 8 hours.
  
  
  CONCLUSIONS
  Topical therapy with Maalox and diphenhydramine or viscous lidocaine was administered to 73% and 15% of the patients, respectively, whereas acyclovir was administered to only 17%. Dosing and administration of topical agents in the treatment of primary herpetic gingivostomatitis in preschoolers were problematic. Acyclovir was not being used as often as it could have been.
authors.affiliation: Department of Pediatrics, School of Medicine, State University of New York at Buffalo, Women and Children's Hospital of Buffalo, Buffalo, NY 14222, USA. hfaden@upa.chob.edu
authors.forename: Howard
authors.initials: H
authors.lastname: Faden
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use; D000284:Administration, Oral; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000779:Anesthetics, Local / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004155:Diphenhydramine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D005440:Fluid Therapy; D006801:Humans; D015994:Incidence; D007223:Infant; D008012:Lidocaine / Q000627:therapeutic use; D008276:Magnesium Hydroxide / Q000627:therapeutic use; D008297:Male; D009518:New York / Q000453:epidemiology; D013283:Stomatitis, Herpetic / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*
chemical_list: D000700:Analgesics; D000779:Anesthetics, Local; D000863:Antacids; D000998:Antiviral Agents; D004338:Drug Combinations; C013591:aluminum hydroxide, magnesium hydroxide, drug combination; D000536:Aluminum Hydroxide; D004155:Diphenhydramine; D008012:Lidocaine; D008276:Magnesium Hydroxide; D000212:Acyclovir